HBV programs also provide an excellent opportunity for learning how the Global Fund for Children's Vaccines can help reduce barriers to vaccine introduction. Many people believe that Hib is not a problem in Asia. However, this may be primarily due to lack of reliable data. CVP is supporting studies to determine the true extent of Hib infection in Indonesia, Thailand, China, Korea, and Vietnam. CVP is supporting landmark pneumococcal studies in The Gambia and the Philippines.
Further studies are underway or planned in Asia, Africa, Latin America, and the former Soviet Union.
Rotavirus Vaccine Concerns about the safety of the first licensed rotavirus vaccine have led to its removal from the market. Safer formulations are expected in two to four years. On advice from its Strategic Advisory Council and its partners, CVP will support crucial studies of rotavirus disease burden to guide introduction of better vaccines in the future. Japanese Encephalitis and Yellow Fever Vaccines CVP will support major regional initiatives to introduce these underutilized vaccines into national immunization programs in countries where needed.